Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-54310
Grote, V A; Rohrmann, S; Nieters, A; Dossus, L; Tjønneland, A; Halkjær, J; Overvad, K; Fagherazzi, G; Boutron-Ruault, M C; Morois, S; Teucher, B; Becker, S; Sluik, D; Boeing, H; Trichopoulou, A; Lagiou, P; Trichopoulos, D; Palli, D; Pala, V; Tumino, R; Vineis, P; Panico, S; Rodríguez, L; Duell, E J; Molina-Montes, E; Dorronsoro, M; Huerta, J M; Ardanaz, E; Jeurnink, S M; Beulens, J W J; Peeters, P H M; Sund, M; Ye, W; Lindkvist, B; Johansen, D; Khaw, K T; Wareham, N; Allen, N; Crowe, F; Jenab, M; Romieu, I; Michaud, D S; Riboli, E; Romaguera, D; Bueno-de-Mesquita, H B; Kaaks, R (2011). Diabetes mellitus, glycated haemoglobin and C-peptide levels in relation to pancreatic cancer risk: a study within the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. Diabetologia, 54(12):3037-3046.
| Published Version PDF - Registered users only 155Kb | ||
| Accepted Version 155Kb |
Abstract
Our data on HbA(1c) show that individuals who develop exocrine pancreatic cancer tend to have moderate increases in HbA(1c) levels, relatively independently of obesity and insulin resistance-the classic and major risk factors for type 2 diabetes. While there is no strong difference by lag time, more data are needed on this in order to reach a firm conclusion.
| Item Type: | Journal Article, refereed, original work |
|---|---|
| Communities & Collections: | 04 Faculty of Medicine > Institute of Social and Preventive Medicine |
| DDC: | 610 Medicine & health |
| Language: | English |
| Date: | 2011 |
| Deposited On: | 25 Jan 2012 13:41 |
| Last Modified: | 23 May 2013 13:19 |
| Publisher: | Springer |
| ISSN: | 0012-186X |
| Additional Information: | The original publication is available at www.springerlink.com |
| Publisher DOI: | 10.1007/s00125-011-2316-0 |
| PubMed ID: | 21953276 |
| WoS Citation Count: | 4 |
Users (please log in): suggest update or correction for this item
Repository Staff Only: item control page